| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.65B | 11.30B | 11.21B | 10.21B | 8.63B | 6.15B |
| Gross Profit | 4.55B | 4.39B | 4.38B | 4.04B | 3.37B | 1.95B |
| EBITDA | 1.87B | 1.85B | 1.94B | 1.88B | 1.57B | 534.59M |
| Net Income | 1.20B | 1.20B | 1.29B | 1.24B | 985.84M | 175.84M |
Balance Sheet | ||||||
| Total Assets | 6.63B | 6.00B | 5.71B | 5.37B | 4.76B | 5.09B |
| Cash, Cash Equivalents and Short-Term Investments | 242.75M | 703.20M | 766.59M | 737.88M | 431.56M | 1.05B |
| Total Debt | 2.29B | 1.92B | 1.91B | 1.90B | 1.85B | 1.90B |
| Total Liabilities | 4.03B | 3.51B | 3.43B | 3.41B | 3.23B | 3.09B |
| Stockholders Equity | 2.60B | 2.49B | 2.28B | 1.96B | 1.54B | 2.00B |
Cash Flow | ||||||
| Free Cash Flow | 952.12M | 964.15M | 1.04B | 1.17B | 887.08M | 658.49M |
| Operating Cash Flow | 1.30B | 1.34B | 1.48B | 1.48B | 1.06B | 810.36M |
| Investing Cash Flow | -751.61M | -383.09M | -441.43M | -314.58M | -176.48M | -48.75M |
| Financing Cash Flow | -715.88M | -1.02B | -1.01B | -861.01M | -1.50B | -107.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $26.95B | 23.29 | 47.97% | ― | 5.45% | 4.28% | |
76 Outperform | $1.47B | 7.93 | 27.54% | ― | -0.42% | 31.64% | |
70 Outperform | $38.51B | 18.54 | 42.43% | 1.38% | 4.89% | 17.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $5.50B | 38.98 | ― | ― | 1.98% | -20.98% | |
54 Neutral | $13.48B | 67.09 | 59.58% | ― | 9.80% | -46.84% | |
53 Neutral | $4.05B | 6.08 | ― | 4.16% | -1.04% | -20.88% |
On December 15, 2025, Ulta Beauty, Inc. adopted a new Executive Severance Plan that standardizes severance and benefits for its executive officers in the event of an involuntary termination without cause, excluding terminations tied to a change in control, death, or disability. Under the plan, eligible executives will receive two times base salary paid over 24 months, a cash lump sum equal to one times the lower of their target or actual annual bonus for the year of termination, and up to 12 months of company-paid COBRA premiums, contingent on signing a release of claims and complying with restrictive covenants for 24 months; the plan replaces prior severance arrangements for executives but leaves intact the company’s existing change-in-control severance framework, signaling a move toward more unified and predictable executive exit terms for stakeholders.
On October 16, 2025, Ulta Beauty announced the appointment of Christopher DelOrefice as Chief Financial Officer, effective December 5, 2025. DelOrefice, who has extensive experience in financial leadership roles at Becton Dickinson & Company and Johnson & Johnson, will replace interim CFO Chris Lialios. This strategic appointment is expected to bolster Ulta Beauty’s financial operations and support its long-term growth strategy. DelOrefice’s compensation package includes a base salary, cash incentives, and equity awards, reflecting the company’s commitment to attracting top talent to drive its financial performance and shareholder value.